Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Nihon Medi-Physics Co. Ltd. has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 6 examiners and 3 art units, so examiner assignments are broadly distributed while multiple matters share technical venues.
DONOHUE, SEAN R is the busiest examiner, with 1 pending matter. No examiner has a larger listed allocation, which favors centralized portfolio oversight rather than reliance on one examiner relationship.
The concentration across 3 art units creates an opportunity to identify recurring examination themes, including claim interpretation and prior-art treatment. Counsel should still preserve matter-specific responses because the six examiner assignments may produce different procedural and substantive concerns.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §112 only | 1 (17%) |
| Double-patenting + other | 2 (33%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
| PRIEST, JESSICA MARIE | 1 | — | — |
| SCHLIENTZ, LEAH H | 1 | 41.8% | +38.7% |
| JARRELL, NOBLE E | 1 | 80.9% | +10.0% |
| DICKINSON, PAUL W | 1 | 63.2% | +9.6% |
| ROBINSON, MIKHAIL O'DONNEL | 1 | 58.3% | +43.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18550479 | COMPOUND, METHOD FOR PRODUCING AND METHOD FOR STORING COMPOUND, METHOD FOR PRODUCING TARGETING AGENT, AND COMPOSITION | JARRELL, NOBLE E | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18005129 | METHOD FOR PRODUCING 225AC SOLUTION | DICKINSON, PAUL W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688001 | RADIOACTIVE COMPLEX OF DEGLYCOSYLATED ANTIBODY AND RADIOACTIVE PHARMACEUTICAL PRODUCT | DONOHUE, SEAN R | — |
| 18556577 | RADIOACTIVE ANTITUMOR AGENT | SCHLIENTZ, LEAH H | — |
| 18550479 | COMPOUND, METHOD FOR PRODUCING AND METHOD FOR STORING COMPOUND, METHOD FOR PRODUCING TARGETING AGENT, AND COMPOSITION | JARRELL, NOBLE E | — |
| 17632994 | METHOD FOR PRODUCING RADIOACTIVE METAL COMPLEX | ROBINSON, MIKHAIL O'DONNEL | — |
| Art Unit | Apps |
|---|---|
| 1618 | 4 |
| 1699 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18688001 | RADIOACTIVE COMPLEX OF DEGLYCOSYLATED ANTIBODY AND RADIOACTIVE PHARMACEUTICAL PRODUCT | DONOHUE, SEAN R | 1618 | §102§103§112DP | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18556582 | HUMANISED ANTIBODIES LABELLED WITH RADIONUCLIDES THAT EMIT BETA-RAYS | PRIEST, JESSICA MARIE | 1618 | §103§112DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18556577 | RADIOACTIVE ANTITUMOR AGENT | SCHLIENTZ, LEAH H | 1618 | §103 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18550479 | COMPOUND, METHOD FOR PRODUCING AND METHOD FOR STORING COMPOUND, METHOD FOR PRODUCING TARGETING AGENT, AND COMPOSITION | JARRELL, NOBLE E | 1699 | §112 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18005129 | METHOD FOR PRODUCING 225AC SOLUTION | DICKINSON, PAUL W | 1618 | §103§112 | Non-Final OA | — | Pending | Jan 11, 2023 |
| 17632994 | METHOD FOR PRODUCING RADIOACTIVE METAL COMPLEX | ROBINSON, MIKHAIL O'DONNEL | 1627 | §103 | Non-Final OA | — | Pending | Feb 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNihon Medi-Physics Co. Ltd. has 6 pending office actions as of October 2026, spread across 3 art units and 6 examiners.
Sean R Donohue has the most, with 1 of Nihon Medi-Physics Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
